Skip to main content
VCbacked
Log inGet Started

Artizan Biosciences

New York, United States

Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.

$1.5M raised
Nov 2025
Venture - Series Unknown
BiopharmaBiotechnologyHealth CareLife Science

Top Investors

Hatteras Venture PartnersConnecticut InnovationsBrii BiosciencesOUP (Osage University Partners)Biohaven Pharmaceutical

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Artizan Biosciences

How much funding has Artizan Biosciences raised?
Artizan Biosciences has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Who are Artizan Biosciences's investors?
Artizan Biosciences's investors include Hatteras Venture Partners, Connecticut Innovations, Brii Biosciences, OUP (Osage University Partners), Biohaven Pharmaceutical.
Where is Artizan Biosciences headquartered?
Artizan Biosciences is headquartered in New York, United States.
What does Artizan Biosciences do?
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
What stage is Artizan Biosciences at?
Artizan Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Artizan Biosciences — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/artizan-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2025). Artizan Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/artizan-biosciences
Wikipedia (cite web)
{{cite web |title=Artizan Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/artizan-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego